2016 ACC/AHA/HFSAFocused Update on New Pharmacological
Therapy for Heart Failure: An Update of the 2013 ACCF/AHA
Guideline for the Management of Heart Failure
AReport of theAmerican College of Cardiology/American Heart
Association Task Force on Clinical Practice Guidelines and the Heart
Failure Society ofAmerica
Developed in Collaboration With the American College of Chest Physicians and International Society
for Heart and Lung Transplantation
WRITING COMMITTEE MEMBERS *
Clyde W. Yancy, MD, MSc, MACC, FAHA, FHFSA, Chair,Mariell Jessup, MD, FACC, FAHA, FESC, Vice Chair,
Biykem Bozkurt, MD, PhD, FACC, FAHA,
†
Javed Butler, MD, MBA, MPH, FACC, FAHA,
‡
Donald E. CaseyJr, MD, MPH, MBA, FACC,
§
Monica M. Colvin, MD, FAHA,
‖
Mark H. Drazner, MD, MSc, FACC, FAHA,
‡
Gerasimos Filippatos, MD, FESC,Gregg C. Fonarow, MD, FACC, FAHA, FHFSA,
‡
Michael M. Givertz, MD, FACC, FHFSA,
¶
Steven M. Hollenberg, MD, FACC,
#
JoAnn Lindenfeld, MD, FACC, FAHA, FHFSA,
¶
Frederick A. Masoudi, MD, MSPH, FACC,**
Patrick E. McBride, MD, MPH, FACC,
††
Pamela N. Peterson, MD, FACC,
‡
Lynne Warner Stevenson, MD, FACC,‡AND
Cheryl Westlake, PhD, RN, ACNS-BC, FHFSA
¶
ACC/AHA TASK FORCE MEMBERS
Jonathan L. Halperin, MD, FACC, FAHA, Chair,Glenn N. Levine, MD, FACC, FAHA, Chair-Elect,
Sana M. Al-Khatib, MD, MHS, FACC, FAHA,Kim K. Birtcher, PharmD, MS, AACC,Biykem Bozkurt, MD, PhD, FACC, FAHA,
Ralph G. Brindis, MD, MPH, MACC,Joaquin E. Cigarroa, MD, FACC,Lesley H. Curtis, PhD, FAHA,
Lee A. Fleisher, MD, FACC, FAHA,Federico Gentile, MD, FACC,Samuel Gidding, MD, FAHA,Mark A. Hlatky, MD, FACC,
John Ikonomidis, MD, PhD, FAHA,José Joglar, MD, FACC, FAHA,Susan J. Pressler, PhD, RN, FAHA, AND
Duminda N. Wijeysundera, MD, PhD
Key Words:AHA Scientific Statements, angioedema, angiotensin-converting enzyme inhibitors, angiotensin
receptor blockers, angiotensin receptor-neprilysin inhibitor, beta blockers, focused update, heart failure,
ivabradine, natriuretic peptides.
This document was approved by the American Colleg
2016 ACC_AHA_HFSA .pdf